|
1
|
Olnes MJ and Erlich R: A review and update
on cholangiocarcinoma. Oncology. 66:167–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khan SA, Emadossadaty S, Ladep NG, Thomas
HC, Elliott P, Taylor-Robinson SD and Toledano MB: Rising trends in
cholangiocarcinoma: Is the ICD classification system misleading us?
J Hepatol. 56:848–854. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bertuccio P, Bosetti C, Levi F, Decarli A,
Negri E and La Vecchia C: A comparison of trends in mortality from
primary liver cancer and intrahepatic cholangiocarcinoma in Europe.
Ann Oncol. 24:1667–1674. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ghouri YA, Mian I and Blechacz B: Cancer
review: Cholangiocarcinoma. J Carcinog. 14:12015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shin HR, Oh JK, Masuyer E, Curado MP,
Bouvard V, Fang YY, Wiangnon S, Sripa B and Hong ST: Epidemiology
of cholangiocarcinoma: An update focusing on risk factors. Cancer
Sci. 101:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sriamporn S, Pisani P, Pipitgool V,
Suwanrungruang K, Kamsa-ard S and Parkin DM: Prevalence of
Opisthorchis viverrini infection and incidence of
cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int
Health. 9:588–594. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bundhamcharoen K, Odton P, Phulkerd S and
Tangcharoensathien V: Burden of disease in Thailand: Changes in
health gap between 1999 and 2004. BMC Public Health. 11:532011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jarnagin W and Winston C: Hilar
cholangiocarcinoma: Diagnosis and staging. HPB (Oxford). 7:244–251.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Valle JW, Wasan H, Johnson P, Jones E,
Dixon L, Swindell R, Baka S, Maraveyas A, Corrie P, Falk S, et al:
Gemcitabine alone or in combination with cisplatin in patients with
advanced or metastatic cholangiocarcinomas or other biliary tract
tumours: A multicentre randomised phase II study-The UK ABC-01
Study. Br J Cancer. 101:621–627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bommer UA and Thiele BJ: The
translationally controlled tumour protein (TCTP). Int J Biochem
Cell Biol. 36:379–385. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Susini L, Besse S, Duflaut D, Lespagnol A,
Beekman C, Fiucci G, Atkinson AR, Busso D, Poussin P, Marine JC, et
al: TCTP protects from apoptotic cell death by antagonizing bax
function. Cell Death Differ. 15:1211–1220. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chung S, Kim M, Choi W, Chung J and Lee K:
Expression of translationally controlled tumor protein mRNA in
human colon cancer. Cancer Lett. 156:185–190. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arcuri F, Papa S, Carducci A, Romagnoli R,
Liberatori S, Riparbelli MG, Sanchez JC, Tosi P and del Vecchio MT:
Translationally controlled tumor protein (TCTP) in the human
prostate and prostate cancer cells: Expression, distribution, and
calcium binding activity. Prostate. 60:130–140. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan TH, Chen L, Liu M, Hu L, Zheng BJ,
Poon VK, Huang P, Yuan YF, Huang JD, Yang J, et al: Translationally
controlled tumor protein induces mitotic defects and chromosome
missegregation in hepatocellular carcinoma development. Hepatology.
55:491–505. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kloc M, Tejpal N, Sidhu J, Ganachari M,
Flores-Villanueva P, Jennings NB, Sood AK, Kubiak JZ and Ghobrial
RM: Inverse relationship between TCTP/RhoA and p53/cyclin A/actin
expression in ovarian cancer cells. Folia Histochem Cytobiol.
50:358–367. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma Q, Geng Y, Xu W, Wu Y, He F, Shu W,
Huang M, Du H and Li M: The role of translationally controlled
tumor protein in tumor growth and metastasis of colon
adenocarcinoma cells. J Proteome Res. 9:40–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gu X, Yao L, Ma G, Cui L, Li Y, Liang W,
Zhao B and Li K: TCTP promotes glioma cell proliferation in vitro
and in vivo via enhanced β-catenin/TCF-4 transcription. Neuro
Oncol. 16:217–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Graidist P, Yazawa M, Tonganunt M,
Nakatomi A, Lin CC, Chang JY, Phongdara A and Fujise K: Fortilin
binds Ca2+ and blocks Ca2+-dependent
apoptosis in vivo. Biochem J. 408:181–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bae SY, Kim HJ, Lee KJ and Lee K:
Translationally controlled tumor protein induces epithelial to
mesenchymal transition and promotes cell migration, invasion and
metastasis. Sci Rep. 5:80612015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu SM and Raine L: Protein A, avidin, and
biotin in immunohistochemistry. J Histochem Cytochem. 29:1349–1353.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Namwat N, Puetkasichonpasutha J, Loilome
W, Yongvanit P, Techasen A, Puapairoj A, Sripa B, Tassaneeyakul W,
Khuntikeo N and Wongkham S: Downregulation of
reversion-inducing-cysteine-rich protein with Kazal motifs (RECK)
is associated with enhanced expression of matrix metalloproteinases
and cholangiocarcinoma metastases. J Gastroenterol. 46:664–675.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amson R, Pece S, Lespagnol A, Vyas R,
Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S,
Wynendaele J, et al: Reciprocal repression between P53 and TCTP.
Nat Med. 18:91–99. 2012. View
Article : Google Scholar
|
|
23
|
Gnanasekar M, Thirugnanam S, Zheng G, Chen
A and Ramaswamy K: Gene silencing of translationally controlled
tumor protein (TCTP) by siRNA inhibits cell growth and induces
apoptosis of human prostate cancer cells. Int J Oncol.
34:1241–1246. 2009.PubMed/NCBI
|
|
24
|
Zhao X and Guan JL: Focal adhesion kinase
and its signaling pathways in cell migration and angiogenesis. Adv
Drug Deliv Rev. 63:610–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sulzmaier FJ, Jean C and Schlaepfer DD:
FAK in cancer: Mechanistic findings and clinical applications. Nat
Rev Cancer. 14:598–610. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alfonso P, Dolado I, Swat A, Núñez A,
Cuadrado A, Nebreda AR and Casal JI: Proteomic analysis of p38alpha
mitogen-activated protein kinase-regulated changes in membrane
fractions of RAS-transformed fibroblasts. Proteomics. 6 Suppl
1:S262–S271. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Murphy G and Nagase H: Progress in matrix
metalloproteinase research. Mol Aspects Med. 29:290–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li YF, Xu XB, Chen XH, Wei G, He B and
Wang JD: The nuclear factor-κB pathway is involved in matrix
metalloproteinase-9 expression in RU486-induced endometrium
breakdown in mice. Hum Reprod. 27:2096–2106. 2012. View Article : Google Scholar : PubMed/NCBI
|
